Market revenue in 2023 | USD 355.5 million |
Market revenue in 2030 | USD 672.4 million |
Growth rate | 9.5% (CAGR from 2023 to 2030) |
Largest segment | Dogs |
Fastest growing segment | Cats |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dogs, Cats |
Key market players worldwide | Merck & Co Inc, Zoetis, BD, Boehringer Ingelheim, ACON Laboratories, Taidoc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pet diabetes care market will help companies and investors design strategic landscapes.
Dogs was the largest segment with a revenue share of 52.38% in 2023. Horizon Databook has segmented the Asia Pacific pet diabetes care market based on dogs, cats covering the revenue growth of each sub-segment from 2018 to 2030.
Japan dominated the Asia Pacific market in 2022 and India is anticipated to register the fastest growth from 2023 to 2030. Overall, Asia Pacific is expected to witness high growth in the near future due to factors such as a significant pet population, growing expenditure on pets, pet humanization, and initiatives by key market participants.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific pet diabetes care market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific pet diabetes care market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account